AN2 Therapeutics, Inc.
ANTX
$4.27
-$0.45-9.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -30.64% | -33.72% | -39.82% | -41.28% | -22.07% |
| Total Receivables | 200.00% | -40.00% | 33.33% | -- | -78.57% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -55.80% | -54.18% | 61.97% | 4.56% | 29.36% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -30.52% | -34.47% | -37.15% | -40.20% | -21.94% |
|
|
|||||
| Total Current Assets | -30.52% | -34.47% | -37.15% | -40.20% | -21.94% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -70.85% | -22.91% |
| Total Assets | -32.73% | -31.17% | -30.10% | -32.92% | -33.63% |
|
|
|||||
| Total Accounts Payable | -8.92% | 30.10% | 12.10% | 26.30% | 23.95% |
| Total Accrued Expenses | -27.08% | -36.72% | -45.95% | -42.19% | -42.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 55.37% | -85.65% | 28.26% | 14.95% | 18.41% |
| Total Other Current Liabilities | 55.37% | -85.65% | 28.26% | 14.95% | 18.41% |
| Total Current Liabilities | -14.83% | -31.54% | -31.05% | -24.84% | -27.10% |
|
|
|||||
| Total Current Liabilities | -14.83% | -31.54% | -31.05% | -24.84% | -27.10% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -13.17% | -31.54% | -31.05% | -24.84% | -27.10% |
|
|
|||||
| Common Stock & APIC | 2.21% | 2.36% | 2.75% | 2.87% | 3.12% |
| Retained Earnings | -17.09% | -17.14% | -20.15% | -26.51% | -33.23% |
| Treasury Stock & Other | 83.87% | -42.86% | 192.59% | -9.43% | -88.73% |
| Total Common Equity | -35.17% | -31.13% | -30.01% | -33.70% | -34.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.17% | -31.13% | -30.01% | -33.70% | -34.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.17% | -31.13% | -30.01% | -33.70% | -34.36% |
|
|
|||||